Alex R. Thurman

CFO Alex R. Thurman sold 10,000 shares of GKOS at $155.00 under pre-arranged 10b5-1 plan; retains 43.7K shares plus 10,000 stock options.

CFO Alex R. Thurman executed a scheduled sale of 10,000 shares at $155.00, reducing his non-derivative holdings by 18.6% to 43.7K shares, conducted under a pre-arranged 10b5-1 trading plan adopted on 2025-12-15. The transaction occurred near the 52-week high ($156.60, within 2.5%), and the stock has appreciated 20.4% over the prior 30 days and 26.7% over 90 days. Thurman maintains 10,000 stock options and retains meaningful non-derivative exposure; the planned nature of this trade reflects administrative portfolio management rather than a discretionary response to company prospects. GLAUKOS remains unprofitable (net income $-19.8M in the latest period) despite strong revenue growth of 32.3% year-over-year and a market cap of $9.0B, a context investors should monitor as the company scales.

CFO Alex Thurman sells 10,000 GKOS shares ($1.5M) under 10b5-1 plan; retains 43,681 shares + 20,000 stock options.

Alex R. Thurman, SVP & Chief Financial Officer, sold 10,000 shares at $150.00 on 2026-07-06 under a pre-arranged 10b5-1 trading plan adopted on 2025-12-15—a scheduled, non-discretionary transaction reducing his non-derivative holdings by 18.6% from 53,681 to 43,681 shares. The sale occurred with GKOS stock at 1.1% below its 52-week high of $154.61 and follows strong recent momentum (+25.4% over 30 days, +28.0% over 90 days), yet represents part of a structured divestment program rather than an opportunistic decision. Materially, Glaukos reported revenue of $150.6M in the latest quarter and remains unprofitable with negative net income of $-19.8M for the full fiscal year, despite robust annual revenue growth of +32.3%—a company in expansion mode but burning cash. Thurman retains meaningful equity exposure through 43,681 non-derivative shares and 20,000 stock option holdings, preserving significant upside participation in the company's turnaround trajectory.

CFO exercises 10,000 shares and sells same-day total for $1.4M; 34th open-market sale in 36 months.

Thurman Alex R., the company's SVP and Chief Financial Officer, exercised 10,000 shares at $38.68 and sold the identical quantity the same day at $140.00—a transaction pattern that nets zero share change but generates liquidity of $1.4 million. This same-day exercise-and-sell is his 34th open-market sale over the past 36 months, with no open-market purchases in that window; the activity reflects a consistent pattern of converting equity awards to cash rather than a sudden conviction shift. The stock trades roughly 5% below its 52-week high and has posted strong gains over the prior 90 days, but the company remains unprofitable year-to-date with a net loss, despite recent revenue growth acceleration. The CFO's filing history shows this is routine equity-conversion activity, not a change in insider positioning.